Researchers identify crucial biomarker that tracks recovery from treatment-resistant depression

A team of leading clinicians, engineers, and neuroscientists has made a groundbreaking discovery in the field of treatment-resistant depression. By analyzing the brain activity of patients undergoing deep brain stimulation (DBS), a promising therapy involving implanted electrodes that stimulate the brain, the researchers identified a unique pattern in brain activity that reflects the recovery process

Oracle Cerner adds generative AI to its EHR platforms

As the Oracle Health Conference gets under way in Las Vegas this week, the company made some new announcements around its Cerner electronic health record, including a big one about a new artificial intelligence integration. WHY IT MATTERS The new Oracle Clinical Digital Assistant technology is meant to help providers use generative AI and voice

Women with gene mutation give new insight into blood clot risk

New research from Queen Mary University of London, published in iScience, shows an increased risk of blood clots in women who have any combination of a particular gene mutation, estrogen use, or common medical conditions—specifically: obesity, high blood pressure, high cholesterol, and kidney disease. Women with the Factor V Leiden (FVL) gene mutation who had

Study shows nearly 300% increase in ADHD medication errors

Attention-deficit/hyperactivity disorder (ADHD) is among the most common pediatric neurodevelopmental disorders. In 2019, nearly 10% of United States (U.S.) children had a diagnosis of ADHD. Approximately 3.3 million children, or roughly 5 out of every 100 children in the U.S., are currently prescribed medication for ADHD. In a new study, published today in Pediatrics, researchers

AI in clinical practice: positive outcomes dominate but questions linger, study finds

In a recent study posted to the medRxiv* preprint server, researchers performed a comprehensive search for randomized controlled trials (RCTs) involving artificial intelligence (AI) algorithms published between 2018 and 2023 on PubMed and the International Clinical Trials Registry Platform (ICTRP).  Specifically, the current scoping review evaluated study endpoints, intervention features, and RCT outcomes to inform stakeholders about